These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning. Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544 [TBL] [Abstract][Full Text] [Related]
7. Duration and Timing of In Utero Opioid Exposure and Incidence of Neonatal Withdrawal Syndrome. Wang Y; Berger L; Durrance C; Kirby RS; Kuo D; Pac J; Ehrenthal DB Obstet Gynecol; 2023 Sep; 142(3):603-611. PubMed ID: 37548391 [TBL] [Abstract][Full Text] [Related]
8. An epidemiological examination of neonatal opioid withdrawal syndrome and maternal and infant characteristics. Schwartz AN; Meschke LL Arch Womens Ment Health; 2024 Oct; 27(5):863-867. PubMed ID: 38573341 [TBL] [Abstract][Full Text] [Related]
9. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age. Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024 [TBL] [Abstract][Full Text] [Related]
10. Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome? Gersch H; Shah D; Chroust A; Bailey B J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2211706. PubMed ID: 37183045 [TBL] [Abstract][Full Text] [Related]
11. Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome. Singleton R; Rutz S; Day G; Hammes M; Wilson AS; Herrick M; Mazut C; Brunner L; Prince J; Desnoyers C; Shaw J; Hirschfeld M; Palis H; Slaunwhite A J Addict Med; 2022 Nov-Dec 01; 16(6):e366-e373. PubMed ID: 35245916 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns. Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312 [TBL] [Abstract][Full Text] [Related]
13. Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome. Bhatt-Mehta V; Jing X; Wang X; Zhu HJ Pharmacotherapy; 2024 Jan; 44(1):22-27. PubMed ID: 37574548 [TBL] [Abstract][Full Text] [Related]
14. Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors. Bakhireva LN; Sparks A; Herman M; Hund L; Ashley M; Salisbury A Pediatr Res; 2022 Mar; 91(4):867-873. PubMed ID: 34588611 [TBL] [Abstract][Full Text] [Related]
15. Maternal opioid use during pregnancy and the risk of neonatal opioid withdrawal syndrome in the offspring. Kristensen AW; Vestermark V; Kjærbye-Thygesen A; Eckhardt MC; Kesmodel US Acta Obstet Gynecol Scand; 2024 Aug; 103(8):1522-1529. PubMed ID: 38700023 [TBL] [Abstract][Full Text] [Related]
16. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018. Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554 [No Abstract] [Full Text] [Related]
17. Severe Neonatal Opioid Withdrawal Requiring Pharmacotherapy: Impact of Region of Residence. Sankaran D; Rawat S; Kachelmeyer JL; Li ES; Reynolds AM; Rawat M; Chandrasekharan P Am J Perinatol; 2024 May; 41(S 01):e654-e663. PubMed ID: 35973797 [TBL] [Abstract][Full Text] [Related]
18. The Influence of Mediators on the Relationship Between Antenatal Opioid Agonist Exposure and the Severity of Neonatal Opioid Withdrawal Syndrome. Devlin LA; Hu Z; Ounpraseuth S; Simon AE; Annett RD; Das A; Fuller JF; Higgins RD; Merhar SL; Smith PB; Crawford MM; Cottrell LE; Czynski AJ; Newman S; Paul DA; Sánchez PJ; Semmens EO; Smith MC; Whalen BL; Snowden JN; Young LW; Matern Child Health J; 2023 Jun; 27(6):1030-1042. PubMed ID: 36905529 [TBL] [Abstract][Full Text] [Related]
19. Association between Individual versus Community-level Social Vulnerability and Neonatal Opioid Withdrawal Syndrome among Pregnant Individuals Receiving Buprenorphine for Opioid Use Disorder. Mason I; Abdelwahab M; Stiles A; Wu J; Venkatesh KK; Rood KM Am J Perinatol; 2024 May; 41(S 01):e3157-e3163. PubMed ID: 37890511 [TBL] [Abstract][Full Text] [Related]
20. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression. Baldo BA Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]